A rational scientific basis for subclassification of antiarrhythmic drugs
- PMID: 3837966
- PMCID: PMC2279697
A rational scientific basis for subclassification of antiarrhythmic drugs
Abstract
The subclassification of Vaughan Williams Class I agents into IA, IB, and IC groups on empiric and clinical grounds has recently been given a cellular electrophysiologic scientific basis. Based on the kinetics of association and dissociation of the drugs with sodium channels, 3 distinct subgroups can be defined. These observations help to explain the clinical utility of the algorithms to use the agents in patients and provide a reference for discussing the new drugs with antiarrhythmic properties being discovered.
Similar articles
-
[New aspects of the electrophysiologic effect of antiarrhythmic agents].Herz. 1990 Apr;15(2):61-9. Herz. 1990. PMID: 2188893 Review. German.
-
Reverse use dependence of antiarrhythmic class Ia, Ib, and Ic: effects of drugs on the action potential duration?Pacing Clin Electrophysiol. 1992 Nov;15(11 Pt 2):2097-102. doi: 10.1111/j.1540-8159.1992.tb03028.x. Pacing Clin Electrophysiol. 1992. PMID: 1279606
-
Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.Cardiovasc Drugs Ther. 1992 Oct;6(5):519-28. doi: 10.1007/BF00055611. Cardiovasc Drugs Ther. 1992. PMID: 1333276 Review.
-
Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?Cardiovasc Drugs Ther. 1991 Aug;5 Suppl 4:805-17. doi: 10.1007/BF00120829. Cardiovasc Drugs Ther. 1991. PMID: 1657110
-
Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.Cardiovasc Res. 1983 Jun;17(6):344-52. doi: 10.1093/cvr/17.6.344. Cardiovasc Res. 1983. PMID: 6883410
Cited by
-
Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model.Front Pharmacol. 2019 Dec 11;10:1374. doi: 10.3389/fphar.2019.01374. eCollection 2019. Front Pharmacol. 2019. PMID: 31920633 Free PMC article.
-
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):228-38. doi: 10.1007/s00399-010-0090-1. Herzschrittmacherther Elektrophysiol. 2010. PMID: 21113605 Review. German.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources